FINANCIAL INFORMATION CONCERNING THE GROUP’S ASSETS AND LIABILITIES, FINANCIAL POSITIONAND PROFITS AND LOSSES 20 • the estimate of the repayments of the conditional advances Note 4: Intangible assets obtained by the Company from public institutions, such as The intangible assets are broken down as follows: Bpifrance Financement. The anticipated repayments of the conditional advances are analyzed at each reporting period (see As of December 31, Note 10), and the measurement of the conditional advances In thousands of euros 2016 2017 classified as financial liabilities based on the effective rate Patents, licenses, trademarks 275 275 method; and Software 10 10 • the measurement of the fair value of the various equity instruments granted to employees, executives or non- Total historical cost 285 285 employee members of the Board of Directors as wel l as Accumulated amort. of patents, 72 90 scientific consultants and service providers, such as AGA, licenses and trademarks SO, BCE or BSA, which is performed on the basis of actuarial Accumulated depreciation of 10 10 software packages models; these models require the use by the Company of certain calculation assumptions such as the expected volatility Accumulated amortization 82 100 of the underlying security (see Note 16). and depreciation Net total 204 185 3.19 Events after the close of the fiscal year The Consolidated Statement of Financial Position and the An intangible asset was recognized at December 31, 2013 as a Consolidated Statement of Income (Loss) of the Group are result of the license agreement signed with Novartis. The initial adjusted to reflect the subsequent events that alter the amounts recognition cost amounted to €275 K and was determined by related to the situations that exist as of the closing date. The reference to the fair value of the 670,588 ordinary shares, €0.41 adjustments are made until the date the Financial Statements are per ordinary share, issued as consideration for the license. approved and authorized for issuance by the Board of Directors There has been no recognition of impairment losses in application on February 27, 2018. of IAS 36 Impairment of Assets over the periods presented. Note 5: Property, plant and equipment Changes in property, plant and equipment gross book values and accumulated depreciation are presented in the following table: As of January 1, 2017 Increase Decrease Currency As of As published Restated (1) translation December 31, In thousands of euros adjustment 2017 Technical equipment and installations 687 277 95 — — 372 Leasehold improvement 143 553 51 — — 604 Office and computer equipment 102 102 41 — — 144 Furniture 256 256 47 — — 303 Fixed assests in progress — — 1 — — 1 Total gross property, plant and equipment 1,188 1,188 236 — — 1,424 Accumulated depreciation of technical 108 83 56 — — 138 equipment and installations Accumulated depreciation of leasehold 67 93 64 — — 157 improvement Accumulated depreciation of office and 62 62 29 — — 91 computer equipment Accumulated depreciation of furniture 93 93 56 — — 149 Accumulated depreciation of fixed assets — — — — — — in progress Total accumulated depreciation 330 330 205 — — 535 Total net property, plant and equipment 1 1 — — — 889 (1) In order to improve the readability of the Financial Statements, some technical equipment are presented together with Leasehold improvement. 196– GENSIGHT BIOLOGICS – 2017 Registration Document